Skip to main content

Brain changes in post-COVID fatigue overlap with MS

By MS Buddy ·

Summarized from EClinicalMedicine, Apr 2023 · PubMed. AI-generated summary. Not medical advice.

Observational study · people after COVID-19, people with MS, and healthy volunteers

Research by Josephine Heine, Carsten Finke and 14 colleagues at Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin and Humboldt-Universität zu Berlin in Germany.

Do brain changes in post-COVID fatigue overlap with those seen in MS?

Key Takeaway

People with lasting fatigue after COVID-19 had brain changes that overlapped with changes seen in people with MS.

Two simple brain silhouettes with muted shaded areas that partly align.
Credibility
Interest
Share:1 min read

What They Found

Brain scans showed changes in areas involved in movement and thinking among people with lasting fatigue after COVID-19. Some changes overlapped with more widespread changes seen in people with MS and fatigue. Certain scan findings were linked to worse fatigue, daytime sleepiness, and trouble with daily life. Changes in brain shape and size were linked to poorer short-term memory. Worse sleep and more signs of depression were linked to worse fatigue, but the severity of the earlier COVID-19 illness was not.

Who Should Care and Why

The study compared people with lasting symptoms after COVID-19, people with MS and fatigue, and healthy volunteers. The MS group served as a comparison, not as the main group being studied. The overlap in brain scans may interest people with MS who experience fatigue. The study also examined memory, sleep, and mood in the post-COVID group. Its findings about what was linked to fatigue came from people after COVID-19, not from the MS group.

Important Considerations

You should know this was an observational study, so it cannot show that brain changes caused fatigue. Researchers recruited 50 people after COVID-19 and included 47 people with MS and fatigue. The abstract does not give the number of healthy volunteers, so the full study size is unclear.

AI-generated summary — for informational purposes only, not medical advice

Read the original abstract

Published in EClinicalMedicine by et al.. Reproduced from the PubMed record.

Post-COVID syndrome is a severe long-term complication of COVID-19. Although fatigue and cognitive complaints are the most prominent symptoms, it is unclear whether they have structural correlates in the brain. We therefore explored the clinical characteristics of post-COVID fatigue, describe associated structural imaging changes, and determine what influences fatigue severity. We prospectively recruited 50 patients from neurological post-COVID outpatient clinics (age 18-69 years, 39f/8m) and matched non-COVID healthy controls between April 15 and December 31, 2021. Assessments included diffusion and volumetric MR imaging, neuropsychiatric, and cognitive testing. At 7.5 months (median, IQR 6.5-9.2) after the acute SARS-CoV-2 infection, moderate or severe fatigue was identified in 47/50 patients with post-COVID syndrome who were included in the analyses. As a clinical control group, we included 47 matched multiple sclerosis patients with fatigue. Our diffusion imaging analyses revealed aberrant fractional anisotropy of the thalamus. Diffusion markers correlated with fatigue severity, such as physical fatigue, fatigue-related impairment in everyday life (Bell score) and daytime sleepiness. Moreover, we observed shape deformations and decreased volumes of the left thalamus, putamen, and pallidum. These overlapped with the more extensive subcortical changes in MS and were associated with impaired short-term memory. While fatigue severity was not related to COVID-19 disease courses (6/47 hospitalised, 2/47 with ICU treatment), post-acute sleep quality and depressiveness emerged as associated factors and were accompanied by increased levels of anxiety and daytime sleepiness. Characteristic structural imaging changes of the thalamus and basal ganglia underlie the persistent fatigue experienced by patients with post-COVID syndrome. Evidence for pathological changes to these subcortical motor and cognitive hubs provides a key to the understanding of post-COVID fatigue and related neuropsychiatric complications. Deutsche Forschungsgemeinschaft (DFG) and German Ministry of Education and Research (BMBF).

The app

Check out the MS Buddy app

It’s free, with no ads. Built by people living with MS.

Download on the App StoreGet it on Google Play

Related MS research

A winding blue paper path curves around ochre shapes toward a resting circle bordered by an incomplete paper ring.
MS fatigue may reflect extra effort to control movement

11/17/2026

A review suggests MS fatigue may reflect extra effort to control movement and incomplete recovery af

Read More
Two paper patchwork circles have similar overall colors but different pieces, with folds hiding or revealing layers.
Computer studies show MS fatigue surveys differ by person

11/16/2026

Computer studies found MS fatigue surveys can give similar group results but different individual sc

Read More
Three soft ribbons in muted clay, sage and blue follow varied, loosely overlapping paths on an off-white background.
Exercise and coping programs helped fatigue in MS review

11/17/2026

A review found exercise, therapy focused on thoughts and behavior, and self-management programs show

Read More
Navy nerve-like lines meet at a central junction, with gaps in their ochre protective sleeves.
MS tissue and mice show damage in a brain vision hub

11/17/2026

Donated MS brain tissue showed damage in a vision hub. Mouse findings linked local immune cell activ

Read More
A blue brain outline beside two loosely intertwined blue and ochre paths with varying space between them.
Thinking problems linked to sexual difficulties in MS

1/1/2026

A study of 318 people with MS linked lower thinking test scores to more sexual difficulties, with th

Read More
Brain outline filled with fine, branching nerve fibers on an off-white background.
In relapsing MS, Mavenclad users' thinking scores rose

11/14/2026

In a review of records for 173 people taking Mavenclad for MS, most had no relapses over two years.

Read More

Not all studies carry the same weight: sample size, study design and whether results were replicated all matter. The credibility score above reflects the journal, and the original paper is linked under More Details. Read how MS Buddy selects and scores research, and talk to your MS care team before acting on any study.